An exploratory assessment of the effect of bazedoxifene on glucose metabolism and bone quality in postmenopausal women with type 2 diabetes.
Phase of Trial: Phase I
Latest Information Update: 18 May 2016
At a glance
- Drugs Bazedoxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 28 Nov 2013 Planned end date 31 Mar 2014 added as reported by University Hospital Medical Information Network - Japan.
- 28 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 21 Feb 2013 New trial record